The results offer some of the first glimpses into real-world findings of the Janus kinase inhibitor in patients with ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Anosmia, dysgeusia, and malnutrition are all common in patients with chronic kidney disease, but more research is needed to ...

Infection was a leading cause of death in lower-risk myelodysplastic syndromes (MDS), highlighting the need for vigilant ...

Panelists discuss how Janus kinase (JAK) inhibitors like pacritinib offer crucial treatment options for myelofibrosis patients with severe thrombocytopenia (platelet counts <50,000 ), highlighting its ...

Almost 60% of patients with obesity and preexisting anemia achieve anemia recovery within 6 months following metabolic ...

New data show strong overall survival rates, building on previously reported outcomes with efti plus pembrolizumab for head ...

However, aplastic anemia is a completely different and far more serious condition. In aplastic anemia, the bone marrow, ...

The findings, published in Reviews in Cardiovascular Medicine, suggest that anemia may significantly strengthen the association between elevated BUN and atherosclerotic cardiovascular disease (ASCVD), ...

More blood donors are needed to meet the needs of Thalassemia patients in the Davao region. Thalassemia is an hereditary form ...

A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.